Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × trametinib × 90 days × Clear all

Sponsor

Conditions

Melanoma 12 Carcinoma, Non-Small-Cell Lung 8 Multiple Myeloma 6 Glioma 6 Colorectal Neoplasms 6 Hematologic Neoplasms 4 Neoplasm Metastasis 3 Lymphoma 3 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Neurofibromatosis 1 2 Neoplasms 2 Lung Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Glioblastoma 2 Astrocytoma 2 Uveal Melanoma 1 Thyroid Cancer, Papillary 1 Solid Tumors, KRAS Mutation; SOS1 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Neoplasms by Site 1

Interventions

Carboplatin 19 durvalumab 18 Etoposide 18 atezolizumab 17 PM 01183 10 Topotecan 8 pembrolizumab 6 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Drug Therapy 5 Paclitaxel 4 Bevacizumab 4 AMG 757 4 anlotinib 3 amrubicin 3 Temozolomide 3 Radiotherapy 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Cisplatin 3 tremelimumab 2 toripalimab 2 sacituzumab govitecan 2 olaparib 2 monalizumab 2 enzalutamide 2 cabozantinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡